GSK Clocks 10% Growth In Q1 Sales Excluding COVID-19 Products, Reaffirms Guidance
None GSK plc (NYSE: GSK) reported Q1 FY23 sales of £6.95 billion, down 3% Y/Y on the actual exchange rate and 8% on the constant exchange rate. • None…
Source: biztoc.com